目前就职于中南大学湘雅医院 医师＆在站博士后
研究方向：表观遗传调控与结直肠癌
教育经历：
2020年9月-2023年6月 中山大学，附属第六医院，外科学临床型博士，导师：骆衍新
2016年8月-2019年6月 中南大学，湘雅医院，外科学临床型硕士
2011年9月-2016年6月 中南大学，湘雅医学院，临床医学，学士
学术简介：
主要研究领域是消化道疾病的临床和基础研究，以第一作者/通讯作者在J Natl Compr Canc Netw、Clin Transl Med、Dig Liver Dis和Cancer Med等国际知名期刊发表SCI论著10篇，2篇IF>10，单篇论著最高影响因子13.4，累计影响因子57.4，中文核心期刊论文7篇。参与国家自然科学基金面上项目和授权发明专利各1项。硕博期间共获得2次研究生国家奖学金及多次校、企奖学金。
已发表学术论文：
1. Dingcheng Shen#, Jinxin Lin#, Yumo Xie, Zhuokai Zhuang, Gaopo Xu, Shaoyong Peng, Guannan Tang, Liangliang Bai, Mingxuan Zhu, Yu Zhang, Ziying Huang, Puning Wang, Xiaoxia Liu, Meijin Huang, Yanxin Luo*, Xiaolin Wang*, Huichuan Yu*. RNA demethylase ALKBH5 promotes colorectal cancer progression by posttranscriptional activation of RAB5A in an m6A-YTHDF2-dependent manner. Clinical and Translational Medicine. 2023.13(5):e1279. (IF: 10.6)
2. Dingcheng Shen, Xiaolin Wang, Heng Wang, Gaopo Xu, Yumo Xie, Zhuokai Zhuang, Ziying Huang, Juan Li, Jinxin Lin, Puning Wang, Meijin Huang, Yanxin Luo, Huichuan Yu*. Current surveillance after treatment is not sufficient for patients with rectal cancer with negative baseline CEA. Journal of the National Comprehensive Cancer Network. 2022. 20(6): 653-662. (IF: 13.4)
3. Dingcheng Shen#, Puning Wang#, Yumo Xie, Zhuokai Zhuang, Mingxuan Zhu, Xiaolin Wang, Meijin Huang, Yanxin Luo, Huichuan Yu*. Clinical spectrum of rectal cancer identifies hallmarks of early-onset patients and next-generation treatment strategies. Cancer Medicine. 2022. 12(3): 3433-3441. (IF: 4.7,封面论文)
4. Haosu Huang, Jie Peng, Caihong Ning, Qin Wei, Jiarong Li, Chiayen Lin, Zefang Sun, Lu Chen, Shuai Zhu, Dingcheng Shen*, Gengwen Huang*. Escherichia coli infection indicates favorable outcomes in patients with infected pancreatic necrosis. Frontiers in Cellular and Infection Microbiology. 2023. 13:1107326. (IF: 6.1,)
5. Chiayen Lin, Abdul Aziz F K Bonsu, Jiarong Li, Caihong Ning, Lu Chen, Shuai Zhu, Qiaoqing Zhong, Dingcheng Shen*, Gengwen Huang*. Application of metagenomic next-generation sequencing for suspected infected pancreatic necrosis. Pancreatology. 2022. 22(7): 864-870. (IF: 3.9)
6. Jiarong Li, Chiayen Lin, Caihong Ning, Qin Wei, Lu Chen, Shuai Zhu, Dingcheng Shen*, Gengwen Huang*. Early-onset emphysematous pancreatitis indicates poor outcomes in patients with infected pancreatic necrosis. Digestive and Liver Disease. 2022. 54(11): 1527-1532. (IF: 5.1)
7. Dingcheng Shen, Qin Wei, Haosu Huang, Caihong Ning, Jiarong Li, Lu Chen, Shuai Zhu, Gengwen Huang*. Synchronous organ failure and infected pancreatic necrosis define genuine critical acute pancreatitis. Digestive and Liver Disease. 2021. 53(12): 1590-1595. (IF: 5.1)
8. Dingcheng Shen, Caixi Tang, Shuai Zhu, Gengwen Huang*. Macrophage migration inhibitory factor is an early marker of severe acute pancreatitis based on the revised Atlanta classification. BMC Gastroenterology. 2021. 21(1): 34-41. (IF: 2.8)
9. Dingcheng Shen#, Di Wang#, Caihong Ning, Chiayen Lin, Xintong Cao, Zhiyong Liu, Liandong Ji, Gengwen Huang*. Prognostic factors of critical acute pancreatitis: A prospective cohort study. Digestive and Liver Disease. 2019. 51(11): 1580-1585. (IF: 5.1)
10. Dingcheng Shen, Caihong Ning, Gengwen Huang*, Zhiyong Liu. Outcomes of infected pancreatic necrosis complicated with duodenal fistula in the era of minimally invasive techniques. Scandinavian Journal of Gastroenterology. 2019. 54(6): 766-772. (IF: 3.0)
